abstract |
The present invention provides a novel 2-aryl-7- (3 ', 4'-dialkoxyphenyl) -pyrazolo [1,5-а] pyrimidine compound represented by Formula 1 or a pharmaceutically acceptable salt thereof, The present invention relates to a pharmaceutical composition for the treatment of inflammation-related diseases, including asthma and chronic obstructive pulmonary disease, characterized in that the preparation method and containing it as an active ingredient.n n n [Formula 1] |